Catalent

2024 - 12 - 14

Press release: Novo Nordisk A/S: Acquisition of Catalent by Novo ... (The Bloomingtonian)

2024 Outlook: The acquisition will have a low single-digit negative impact on operating profit growth and reduce free cash flow by the $11.7 billion USD ...

Post cover
Image courtesy of "Endpoints News"

FTC OKs Novo-Catalent deal, in major win for Novo Nordisk's GLP-1 ... (Endpoints News)

FTC approves Novo Holdings' $16.5B Catalent acquisition. Deal includes selling 3 facilities to Novo Nordisk for $11B, despite concerns from Eli Lilly.

Post cover
Image courtesy of "BNN"

Novo Nordisk Set to Close Catalent Deal Without FTC Challenge (BNN)

Novo Nordisk A/S can advance with its acquisition of factories from contract development and manufacturing organization Catalent Inc. after the Federal ...

Post cover
Image courtesy of "Seeking Alpha"

Novo Nordisk says Catalent buyout to close soon as regulatory ... (Seeking Alpha)

Novo Nordisk's (NVO) acquisition of three Catalent (CTLT) production sites to close soon as its parent wins regulatory nod for the $16.5B deal.

Post cover
Image courtesy of "STAT"

Novo Holdings is set to close its $16.5 billion acquisition of Catalent ... (STAT)

Catalent is an attractive target for Novo Holdings because it is a subcontractor that already helps manufacture the anti-obesity drug Wegovy.

Post cover
Image courtesy of "The North West Star"

Novo Nordisk to boost production with a new acquisition (The North West Star)

Danish pharma company Novo Nordisk, makers of weight-loss drugs Ozempic and Wegovy, plans to expand production based on a takeover of US health products ...

Post cover
Image courtesy of "Yahoo Finance"

Regulatory conditions on Novo Holdings' $16.5 billion Catalent deal ... (Yahoo Finance)

Novo Holdings in February agreed to buy Catalent to boost output of the popular weight-loss drug Wegovy. According to the terms of the deal, Novo Holdings ...

Post cover
Image courtesy of "Reuters"

Regulatory conditions on Novo Holdings' $16.5 bln Catalent deal ... (Reuters)

All regulatory closing conditions related to Novo Holdings' $16.5 billion acquisition of U.S. contract drug maker Catalent had been fulfilled, the companies ...

Post cover
Image courtesy of "Finimize"

Novo Holdings Seals The Deal On Catalent Acquisition (Finimize)

The $16.5 billion acquisition aims to boost Wegovy production while sparking discussions about potential competitive impacts in the US and EU.

Post cover
Image courtesy of "Indiana Daily Student"

Novo's takeover of Catalent set to proceed after FTC declines to ... (Indiana Daily Student)

Catalent is pictured at 1300 S. Patterson Drive in Bloomington. Catalent and Novo Holdings announced Dec. 14 that the companies had fulfilled all regulatory ...

Post cover
Image courtesy of "marketscreener.com"

Novo Holding's purchase of Catalent soon to be completed (marketscreener.com)

Novo Holdings, the major shareholder of Danish pharmaceutical company Novo Nordisk, is close to finalizing its purchase of Catalent.

Post cover
Image courtesy of "NS Healthcare"

Catalent and Novo Holdings to finalise acquisition following ... (NS Healthcare)

The agreement, initially announced in February, involves Novo Holdings acquiring Catalent and Novo Nordisk purchasing three fill-finish manufacturing sites ...

Explore the last week